Drug Type Small molecule drug |
Synonyms ISM 4808, ISM-4808, ISM4808 |
Target |
Action inhibitors |
Mechanism EGLN2 inhibitors(egl-9 family hypoxia inducible factor 2 inhibitors), PHD2 inhibitors(egl-9 family hypoxia inducible factor 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Anemia of renal disease | IND Approval | China | 22 Aug 2023 |





